| Dr Kelli Herlihy Dyer, DO | |
|
6465 S Yale Ave Ste 301, Tulsa, OK 74136-7823 | |
| (918) 502-3500 | |
| (918) 502-3505 |
| Full Name | Dr Kelli Herlihy Dyer |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 16 Years |
| Location | 6465 S Yale Ave Ste 301, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235385766 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 5101017831 (Michigan) | Secondary |
| 207W00000X | Ophthalmology | 5477 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Francis Hospital, Inc | Tulsa, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eyecare Associates Of South Tulsa Pc | 4385646124 | 6 |
| Warren Clinic Inc | 8820900293 | 604 |
News Archive
An international team of scientists led by researchers at Mount Sinai School Medicine have discovered that a drug that had previously yielded conflicting results in clinical trials for Alzheimer's disease effectively stopped the progression of memory deterioration and brain pathology in mouse models of early stage Alzheimer's disease.
Sydney University medical researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS in the latest round of National Health and Medical Research Council program grants.
EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that its CE Mark for the Maestro Rechargeable (RC) System for obesity was expanded to include the management of Type 2 diabetes mellitus through improved glycemic control.
Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare.
Flu season is on its way to homes across Canada. But the question of why influenza epidemics take place in the few cold months of winter remains unanswered. Is it the change in the weather? The return to school? Or increased viral production under winter conditions?
› Verified 3 days ago
| Entity Name | Warren Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174582282 PECOS PAC ID: 8820900293 Enrollment ID: O20031104000252 |
News Archive
An international team of scientists led by researchers at Mount Sinai School Medicine have discovered that a drug that had previously yielded conflicting results in clinical trials for Alzheimer's disease effectively stopped the progression of memory deterioration and brain pathology in mouse models of early stage Alzheimer's disease.
Sydney University medical researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS in the latest round of National Health and Medical Research Council program grants.
EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that its CE Mark for the Maestro Rechargeable (RC) System for obesity was expanded to include the management of Type 2 diabetes mellitus through improved glycemic control.
Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare.
Flu season is on its way to homes across Canada. But the question of why influenza epidemics take place in the few cold months of winter remains unanswered. Is it the change in the weather? The return to school? Or increased viral production under winter conditions?
› Verified 3 days ago
| Entity Name | Eyecare Associates Of South Tulsa Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750475760 PECOS PAC ID: 4385646124 Enrollment ID: O20070208000133 |
News Archive
An international team of scientists led by researchers at Mount Sinai School Medicine have discovered that a drug that had previously yielded conflicting results in clinical trials for Alzheimer's disease effectively stopped the progression of memory deterioration and brain pathology in mouse models of early stage Alzheimer's disease.
Sydney University medical researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS in the latest round of National Health and Medical Research Council program grants.
EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that its CE Mark for the Maestro Rechargeable (RC) System for obesity was expanded to include the management of Type 2 diabetes mellitus through improved glycemic control.
Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare.
Flu season is on its way to homes across Canada. But the question of why influenza epidemics take place in the few cold months of winter remains unanswered. Is it the change in the weather? The return to school? Or increased viral production under winter conditions?
› Verified 3 days ago
| Entity Name | South Tulsa Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104286640 PECOS PAC ID: 1355634023 Enrollment ID: O20160803001541 |
News Archive
An international team of scientists led by researchers at Mount Sinai School Medicine have discovered that a drug that had previously yielded conflicting results in clinical trials for Alzheimer's disease effectively stopped the progression of memory deterioration and brain pathology in mouse models of early stage Alzheimer's disease.
Sydney University medical researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS in the latest round of National Health and Medical Research Council program grants.
EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that its CE Mark for the Maestro Rechargeable (RC) System for obesity was expanded to include the management of Type 2 diabetes mellitus through improved glycemic control.
Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare.
Flu season is on its way to homes across Canada. But the question of why influenza epidemics take place in the few cold months of winter remains unanswered. Is it the change in the weather? The return to school? Or increased viral production under winter conditions?
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kelli Herlihy Dyer, DO 6600 S Yale Ave Ste 1200, Tulsa, OK 74136-3333 Ph: (918) 488-6653 | Dr Kelli Herlihy Dyer, DO 6465 S Yale Ave Ste 301, Tulsa, OK 74136-7823 Ph: (918) 502-3500 |
News Archive
An international team of scientists led by researchers at Mount Sinai School Medicine have discovered that a drug that had previously yielded conflicting results in clinical trials for Alzheimer's disease effectively stopped the progression of memory deterioration and brain pathology in mouse models of early stage Alzheimer's disease.
Sydney University medical researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS in the latest round of National Health and Medical Research Council program grants.
EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that its CE Mark for the Maestro Rechargeable (RC) System for obesity was expanded to include the management of Type 2 diabetes mellitus through improved glycemic control.
Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare.
Flu season is on its way to homes across Canada. But the question of why influenza epidemics take place in the few cold months of winter remains unanswered. Is it the change in the weather? The return to school? Or increased viral production under winter conditions?
› Verified 3 days ago
Mark Justin Weiss, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1717 S Utica Ave, Ste 107, Tulsa, OK 74104 Phone: 918-742-2428 Fax: 918-742-8435 | |
Anthony Economou, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2865 E Skelly Dr Ste 250, Tulsa, OK 74105 Phone: 918-317-0022 Fax: 855-327-9828 | |
Dr. Justin Parschauer, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6600 S Yale Ave, Suite 800, Tulsa, OK 74136 Phone: 918-491-3900 | |
Dr. Zeb Linston Brister, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3906 S Peoria Ave, Tulsa, OK 74105 Phone: 918-585-1523 Fax: 918-584-5520 | |
John Thomas Romano, D.O. Ophthalmology Medicare: Medicare Enrolled Practice Location: 4444 S Harvard Ave, Ste 300, Tulsa, OK 74135 Phone: 918-747-2020 Fax: 918-747-2056 | |
Dr. Bruce Ben Pettigrove, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 6606 S. Yale, #220, Tulsa, OK 74136 Phone: 918-492-4122 Fax: 918-492-7451 | |
Shehzad Y Batliwala, D.O Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10010 E 81st St Ste 100, Tulsa, OK 74133 Phone: 918-250-2020 |